
ELANCO ANIMAL HEALTH INC
ELANNYSETrading Snapshot
- Day Range
- $22.58 β $22.99
- 52-Week Range
- $16.15 β $27.98
- Volume
- $3.18B
- Avg Volume
- $2.44B
- Shares Outstanding
- 499.4M
- Next Earnings
- Oct 3, 2026
Fundamentals Snapshot
- Annual Revenue
- $4.71B
- Last Q Revenue
- $1.37B
- P/E Ratio
- β
- P/S Ratio
- 2.2x
- EPS (TTM)
- $-0.42
- Dividend Yield
- β
Why Investors Own ELAN
- βHigh-growth profile β revenue up +12.3% YoY with expanding US Equity exposure.
- βHealthy economics β 36% gross margin and 12% free-cash-flow margin.
- βNew products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
About ELANCO ANIMAL HEALTH INC
Elanco Animal Health, a firm dedicated to animal well-being, creates, produces, and commercializes a diverse array of solutions for both companion animals and livestock. For household pets, the company provides preventative health solutions, including parasiticides and vaccinations, designed to guard against common ailments like worms, fleas, and ticks, with notable brands such as Seresto, Advantage, Advantix, and Advocate. Additionally, Elanco supplies therapeutic treatments for canine and feline conditions including pain, osteoarthritis, ear infections, cardiovascular issues, and dermatological problems, marketed under labels like Galliprant and Claro. Its portfolio for agricultural animals encompasses vaccines, antibiotics, parasiticides, and other essential products for poultry and aquaculture farming. This segment also features nutritional supplements such as enzymes, probiotics, and prebiotics to support animal health and growth. Furthermore, the company offers a comprehensive suite of products for ruminant and swine operations, comprising vaccines, antibiotics, implants, and parasiticides, often recognized by brands like Rumensin and Baytril. Elanco distributes its offerings through various channels, including independent distributors, veterinary clinics, and a broad spectrum of farm animal producers, from cattle and dairy farms to pig, poultry, and aquaculture enterprises. Established in 1954, Elanco Animal Health Incorporated maintains its corporate headquarters in Greenfield, Indiana.
Otter Score Breakdown
βAnalyst Price Target
βLatest News & Updates
ELANCO ANIMAL HEALTH INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
Analysts lift ELAN price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
ELANCO ANIMAL HEALTH INC announces new agreement to expand its footprint
The move broadens the companyβs reach and could add incremental revenue over the next year.